P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION

P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION

Bibliographic Details
Main Authors:	Nuria Martinez-Cibrian, Sergi Betriu, Valentín Ortiz-Maldonado, Daniel Esteban, Natalia Tovar, Ana Triguero Moreno, Leticia Alserawan, Mercedes Montoro, Anna Van Muyden, Maike Spoon, Margot Pont, Christian Jacques, Julio Delgado
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000972484.02679.4e

Similar Items

CFTR Rescue in Intestinal Organoids with GLPG/ABBV-2737, ABBV/GLPG-2222 and ABBV/GLPG-2451 Triple Therapy
by: Eyleen de Poel, et al.
Published: (2021-09-01)

PB1911: CYTOGENOMIC INTEGRATIVE ANALYSIS OF CLL/SLL PATIENTS AT DISEASE PROGRESSION.
by: Rocío García-Serra, et al.
Published: (2023-08-01)

Transformação da LLC-B: síndrome de Richter Transformation of the CLL-B: Richter’s syndrome
by: Jane A. Dobbin
Published: (2005-12-01)

Targeted therapies in CLL/SLL and the cumulative incidence of infection: A systematic review and meta-analysis
by: Stephanos Vassilopoulos, et al.
Published: (2022-09-01)

P640: ZANUBRUTINIB VS IBRUTINIB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LYMPHOMA (R/R CLL/SLL): IMPACT ON HEALTH-RELATED QUALITY OF LIFE (HRQOL)
by: Barbara Eichhorst, et al.
Published: (2023-08-01)

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
by: Natali Pflug, et al.
Published: (2021-12-01)

Co-Occurrence of EBV-Positive Mucocutaneous Ulcer (EBV-MCU) and CLL/SLL in the Head and Neck Region
by: Patricia Bott, et al.
Published: (2022-04-01)

Contributions to b → sℓℓ anomalies from R-parity violating interactions
by: Kevin Earl, et al.
Published: (2018-08-01)

Use of BTK Inhibitors in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Practical Guidance
by: St-Pierre F, et al.
Published: (2022-07-01)

P625: A PHASE 1B/2 STUDY OF NAVTEMADLIN COMBINED WITH ACALABRUTINIB IN BTK INHIBITOR NAÏVE PATIENTS WITH RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL)
by: John C. Byrd, et al.
Published: (2023-08-01)

Folliculocentric lymphocytic hypersensitivity reactions in CLL/SLL patients: A unique clinicopathologic entity amongst non‐specific hypersensitivity reactions
by: James Abbott, et al.
Published: (2023-06-01)

Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with Reed-Sternberg-like cells with no convincing evidence of classic Hodgkin lymphoma
by: Latha K Abraham, et al.
Published: (2024-01-01)

Hodgkin Variant of Richter’s Transformation in Chronic Lymphocytic leukemia (CLL): An Illustrative Case Report and Literature Review
by: Nishit Gupta, et al.
Published: (2021-10-01)

PB1864: BRUIN CLL-321: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS INVESTIGATOR’S CHOICE OF IDELALISIB+RITUXIMAB OR BENDAMUSTINE+RITUXIMAB IN BTKI PRETREATED CLL/SLL (TRIAL IN PROGRESS)
by: J. P. Sharman, et al.
Published: (2022-06-01)

PB1863: BRUIN CLL-322: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF FIXED DURATION PIRTOBRUTINIB+VENETOCLAX AND RITUXIMAB VS VENETOCLAX AND RITUXIMAB IN PREVIOUSLY TREATED CLL/SLL (TRIAL IN PROGRESS)
by: A. R. Mato, et al.
Published: (2022-06-01)

Ir2 leading to complete remission in r/r richter syndrome – a case report
by: Emin Abdullayev, et al.
Published: (2020-10-01)

Die zerebrale angiographie. H. Krayenruhl, Und HS. R. Richter
by: O. Lange
Published: (1952-12-01)

RİCHTER SYNDROME TRANSFORMATİON UNDER VENETOCLAX TREATMENT: A CASE REPORT OF A 51-YEAR-OLD FEMALE WİTH CLL
by: İbrahim Halil Açar, et al.
Published: (2023-10-01)

What R K and Q 5 can tell us about New Physics in b→sℓℓ transitions?
by: Marcel Algueró, et al.
Published: (2019-07-01)

2-[<sup>18</sup>F]-FDG PET/CT Semiquantitative and Radiomics Predictive Parameters of Richter’s Transformation in CLL Patients
by: Domenico Albano, et al.
Published: (2024-01-01)

P625: SINGLE-CELL RNA SEQUENCING REVEALS THE HETEROGENEITY OF TUMOR CELLS AND IMMUNE MICROENVIRONMENT IN RICHTER SYNDROME AND ACCELERATED CLL
by: Y. Sha, et al.
Published: (2022-06-01)

P621: REAL-WORLD DOSING PATTERNS AND TIME TO NEXT TREATMENT FOR PREVIOUSLY UNTREATED PATIENTS WITH CLL/SLL WITH OR WITHOUT IBRUTINIB DOSE REDUCTION FOLLOWING AN ADVERSE EVENT
by: Mazyar Shadman, et al.
Published: (2023-08-01)

PB1881: IBRUTINIB REDUCES THE RISK OF RICHTER’S TRANSFORMATION IN PREVIOUSLY TREATED CLL PATIENTS: A POPULATION-BASED STUDY IN BRITISH COLUMBIA
by: R. Ramadan, et al.
Published: (2022-06-01)

Concomitant Presence of CD5-Positive Diffuse Large B-Cell Lymphoma and Monoclonal B Cells with the 'CLL Immunophenotype' - Is It Richter's Transformation?
by: Sabina Langer, et al.
Published: (2017-05-01)

Rare case of Richter’s syndrome localization in liver and thyroid of a patient with a chronic lymphocytic leukemia (CLL) – Case report and literature
by: Ewa Wąsik-Szczepanek, et al.
Published: (2020-03-01)

S147: PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON-COVALENT (REVERSIBLE) BTK INHIBITOR IN PREVIOUSLY TREATED CLL/SLL: UPDATED RESULTS FROM THE PHASE 1/2 BRUIN STUDY
by: A. R. Mato, et al.
Published: (2022-06-01)

Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201).
by: John E McKinnon, et al.
Published: (2014-01-01)

S139: BCOR DELETION SUSTAINS NOTCH1 SIGNALLING ACTIVATION TO ACCELERATE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PROGRESSION TOWARD RICHTER TRANSFORMATION IN MICE
by: C. Rompietti, et al.
Published: (2022-06-01)

رویداد ملی آب مشهد، 1399
by: دانشگاه فردوسی مشهد انجمن علمی علوم و مهندسی آب, et al.
Published: (2020-12-01)

شماره 32 متن پاییز 1399
Published: (2020-09-01)

P662: PATIENT-REPORTED OUTCOMES FROM A PHASE 3 RANDOMIZED STUDY OF ZANUBRUTINIB VERSUS BENDAMUSTINE PLUS RITUXIMAB (BR) IN PATIENTS WITH TREATMENT-NAÏVE (TN) CLL/SLL
by: P. Ghia, et al.
Published: (2022-06-01)

Revisiting electroweak radiative corrections to b → sℓℓ in SMEFT
by: Motoi Endo, et al.
Published: (2021-05-01)

The 2012 SLL Code for Lighting: the Impact on Design and Commissioning
by: James Thomas Duff
Published: (2012-11-01)

Identification of GLPG/ABBV-2737, a Novel Class of Corrector, Which Exerts Functional Synergy With Other CFTR Modulators
by: Gert de Wilde, et al.
Published: (2019-05-01)

The cult of St. Edward the Confessor, 1066-1399
by: O'Brien, E, et al.
Published: (2001)

Bothe richter teherani /
by: 464458 Weiss, Klaus-Dieter, et al.
Published: (2005)

Peter Richter – notice
Published: (2017-03-01)

Hérnia de Richter
by: Ana Beatriz Esteves Batista, et al.
Published: (2019-12-01)

Krieg der Richter?
by: Maximilian Steinbeis

Richter auf Kurzarbeit
by: Maximilian Steinbeis